Latanoprost Comp Ratiopharm

Timolol maleate and latanoprost, the active ingredients in Latanoprost Comp Ratiopharm, are a beta‑blocker and a prostaglandin analog presented as eye drops for ocular use. They treat open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost Comp Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost Comp Ratiopharm is used to lower intra‑ocular pressure in conditions affecting the eye's drainage pathways.

Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic nerve damage. Ocular hypertension: lowers pressure to reduce risk of progression to glaucoma. Secondary open‑angle glaucoma: helps control pressure when caused by other ocular conditions.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision shortly after instillation. - Conjunctival hyperemia (eye redness). - Increased eyelash growth or darkening of the iris.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Ocular inflammation or worsening of glaucoma. - Systemic bradycardia, hypotension, or asthma exacerbation.

Before initiating therapy, assess baseline intra‑ocular pressure and cardiovascular status.

Assess intra‑ocular pressure: ensure adequate pressure reduction. Monitor heart rate and blood pressure: watch for systemic beta‑blocker effects. Use with caution in asthma or COPD: beta‑blockade may provoke bronchospasm. Avoid in active eye infection or severe sinusitis: may worsen condition. Do not combine with other prostaglandin analog eye drops: risk of additive side effects. Store at room temperature: keep in original container, protect from moisture and light.

Latanoprost Comp Ratiopharm may interact with several systemic and ocular agents.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers (e.g., propranolol): increased risk of bradycardia. - Other prostaglandin analog eye drops: additive ocular side effects. - Sympathomimetic ophthalmic agents: may reduce efficacy of timolol.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: possible alteration of ocular blood flow. - Topical NSAIDs: may increase ocular irritation. - Anticholinergic eye drops: monitor for changes in pupil size and pressure control.